Joint Formulary & PAD

Berocca - Refeeding syndrome

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Effervescent tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

On advice from specialist NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g.  Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency  

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Berocca
Indication :
Refeeding syndrome
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Berocca is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Refeeding syndrome.

Committee Recommendations (0)

  • No records returned.